about
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncolo...
Read More
20.36
-0.63
(-3.00%)
983.6K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Immunome Inc is on 19 Mar 2026 for the purpose of Immunome Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Immunome Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..